Delivery Order SPE2DB22D3011-SPE2DB24FQ3HC

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Vyvanse 10 mg capsules. The contract has a not-to-exceed ceiling value of $3,448.00 and a completion date of July 22, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 30 mg capsules. The contract has a ceiling value of $4,121.33 and a period of performance through August 13, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to $999,999,999 through December 2025, for the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse (lisdexamfetamine dimesylate) 50 mg capsules. The contract has a ceiling value of $2,851.42 and a completion date of August 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vyvanse 30 mg capsules, a medication used to treat certain neurological conditions. The contract has a ceiling value of $1,272.34 and a period of performance through June 26, 2025. It is a firm fixed-price, non-set-aside contract, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vyvanse 10 mg capsules to support federal healthcare programs. The total ceiling value of this delivery order is $4,763.21, with a period of performance through November 3, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 30 mg capsules. The total ceiling value of the contract is $1,348.00, with a final completion date of September 22, 2023. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 50 mg capsules. The contract has a ceiling value of $1,258.30 and a period of performance through May 9, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse capsules 30mg. The contract has a ceiling value of $35,630.54 and a completion date of June 10, 2025. It is a firm-fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999.00, which provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,529,755 units of Vyvanse 20 mg capsules. The contract has a firm fixed price and a ceiling value of $1,473.92. It is not set aside for any specific business type. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Vyvanse 20 mg capsules. The contract has a firm fixed price of $1,724.00 and an ultimate completion date of August 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FQ3HC
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract is for the supply of Vyvanse 10 mg capsules, a prescription medication. The contract has a ceiling value of $11,847.24 and a completion date of August 21, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has a firm fixed-price pricing type and is not set aside for any particular business category.

Generated 11/19/24, 9:29 AM